Clinical trial
Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer
NCT00002881
Study timeline
Study start (unknown)1996-10-01Date precision: month
Registry last updated2010-11-09
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prostate Cancerunresolved
Interventions
flutamideDRUG · verified · RxNorm: flutamide
goserelin acetateDRUG · verified · RxNorm: goserelin acetate
leuprolide acetateDRUG · verified · RxNorm: leuprolide acetate
suraminDRUG
orchiectomyPROCEDURE
Sponsors & collaborators
Eastern Cooperative Oncology Grouplead sponsor
National Cancer Institute (NCI)collaborator
Cancer and Leukemia Group Bcollaborator
SWOG Cancer Research Networkcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00002881 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.